Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14 Mar 2023 This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more Show/Hide
Our research impact: prostate cancer radiotherapy 12 May 2022 To mark our outstanding success in REF2021, Gege Li spoke to several of our researchers here at the ICR who have pioneered improved use of radiotherapy in the treatment of prostate cancer. Find out more Show/Hide
How the ICR’s pioneering drug research is changing lives 17 May 2019 The ICR has discovered more new cancer drugs than any other academic institution globally, and led the underpinning science for many more cancer treatments. We have helped lead clinical trials of these drugs and many others – taking them to cancer patients as quickly as possible. Find out more Show/Hide